Seroatlas · Human Serome Atlas

GAR1

H/ACA ribonucleoprotein complex subunit 1

Also known as: GAR1_HUMAN, NOLA1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9NY12
Gene
GAR1
Ensembl
ENSG00000109534
Chromosome
4
Canonical length
217 aa
Protein class
Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nucleoli fibrillar center

OverviewNCBI Gene

This gene is a member of the H/ACA snoRNPs (small nucleolar ribonucleoproteins) gene family. snoRNPs are involved in various aspects of rRNA processing and modification and have been classified into two families: C/D and H/ACA. The H/ACA snoRNPs also include the DKC1, NOLA2 and NOLA3 proteins. These four H/ACA snoRNP proteins localize to the dense fibrillar components of nucleoli and to coiled (Cajal) bodies in the nucleus. Both 18S rRNA production and rRNA pseudouridylation are impaired if any one of the four proteins is depleted. These four H/ACA snoRNP proteins are also components of the telomerase complex. The encoded protein of this gene contains two glycine- and arginine-rich domains and is related to Saccharomyces cerevisiae Gar1p. Two splice variants have been found for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

217 residues, UniProt reviewed canonical sequence.

>Q9NY12|GAR1
     1  MSFRGGGRGG FNRGGGGGGF NRGGSSNHFR GGGGGGGGGN FRGGGRGGFG RGGGRGGFNK
    61  GQDQGPPERV VLLGEFLHPC EDDIVCKCTT DENKVPYFNA PVYLENKEQI GKVDEIFGQL
   121  RDFYFSVKLS ENMKASSFKK LQKFYIDPYK LLPLQRFLPR PPGEKGPPRG GGRGGRGGGR
   181  GGGGRGGGRG GGFRGGRGGG GGGFRGGRGG GFRGRGH

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GAR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.57
Highest tissue expression
30 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 30 nTPM
  • esophagus: 21 nTPM
  • skin: 21 nTPM
  • liver: 15 nTPM
  • adrenal gland: 15 nTPM
  • urinary bladder: 15 nTPM

Single-cell type

  • syncytiotrophoblasts: 117 nCPM
  • migrating cytotrophoblasts: 93 nCPM
  • erythrocyte progenitors: 91 nCPM
  • esophageal basal cells: 91 nCPM
  • cytotrophoblasts: 85 nCPM
  • esophageal suprabasal cells: 83 nCPM

Immune cell

  • memory B-cell: 8.5 nTPM
  • naive B-cell: 8 nTPM
  • basophil: 7.6 nTPM
  • NK-cell: 7.3 nTPM
  • T-reg: 6.9 nTPM
  • plasmacytoid DC: 6.8 nTPM

Brain region

  • white matter: 4.8 nTPM
  • cerebral cortex: 4.5 nTPM
  • hypothalamus: 4.5 nTPM
  • pons: 4.3 nTPM
  • medulla oblongata: 4.1 nTPM
  • choroid plexus: 4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.69
gnomAD pLI
0.1
gnomAD missense Z
0.23
DepMap mean gene effect
-0.61
DepMap dependency class
common

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GAR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GAR1 as an antibody target. Whether an autoantibody or antibody against GAR1 could matter depends on whether native GAR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GAR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label GAR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GAR1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...